Zenday App vs Noom GLP-1 Companion: free isn't the same as unattached

Why does a GLP-1 need its own app at all?

Because the medication changes what the problem is. Appetite drops sharply, often unevenly across the dose cycle, and the old skill — eating less than you want — stops being the thing you need help with. Three new problems take its place: getting enough protein into a much smaller appetite, protecting muscle during rapid loss, and getting through the side-effect weeks that follow every dose increase.

Side effects are the single most common reason people stop treatment. That's the failure mode a GLP-1 companion exists to prevent, and it's the reason a general-purpose tracker struggles here no matter how good it is at its own job.

Zenday App was founded in 2025 by Emily Carter, who was taking a GLP-1 herself, and built with a doctor-led team. It now reports more than a million users. Its three pillars are dose-linked daily guidance, side-effect management, and privacy — it runs in a browser, so there's no app icon on your phone and no app-store purchase trail.

Why is Noom's companion free?

Because it is a front door. Noom runs a medication business — its GLP-1 programmes are priced from roughly $179 to $299 a month with medication included, and Noom Med sits at about $99 a month. A free companion that reaches people already on a GLP-1 is an efficient way to meet future customers.

That's a legitimate business model and it doesn't make the product bad. It does mean the app has a second job besides helping you, and second jobs show up in the interface eventually — in what gets recommended, and in what doesn't.

Zenday App has one job. It doesn't prescribe, doesn't dispense, and doesn't have a medication margin to protect, so its guidance about your treatment isn't also a sales channel for its own treatment.

Which one understands the GLP-1 reality better?

Noom's curriculum was built for a pre-GLP-1 world: psychology, food categories, calorie density, cognitive reframing. It's good work, and much of it still applies. But the core problem it was designed to solve — wanting to eat more than you should — is often not the problem a GLP-1 user has.

The GLP-1 problems are different: eating enough, hitting protein when appetite is gone, protecting muscle during rapid loss, and getting through the side-effect weeks that follow a dose increase. Zenday App is built around those, because it was designed by someone who had them.

What Noom GLP-1 is genuinely best at

No app in this comparison is bad, and pretending otherwise would make this page less useful. Here's where Noom GLP-1 leads:

• A genuinely good behaviour-change curriculum, refined over more than a decade
• Price — the GLP-1 Companion is free to anyone on a GLP-1, whoever prescribed it
• Brand familiarity and a large user base, which some people find reassuring
• Coaching access on its paid tiers

The cost framing that actually matters

GLP-1 medication commonly runs $500–$1,000 a month. Against that, the difference between two companion apps is a rounding error — usually less than two days of prescription. The question worth asking isn't which app is cheaper. It's which one makes the expensive thing work harder, and which one keeps you on treatment through the weeks when most people stop.